Search results
AbbVie (ABBV) Up 24% in a Year: Buy, Sell or Hold the Stock?
Zacks via Yahoo Singapore Finance· 2 days agoInvestors who own AbbVie's (ABBV) stock may stay invested as the company has faced its biggest...
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Zacks via Yahoo Singapore Finance· 2 days agoAbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
AbbVie (ABBV) Gains As Market Dips: What You Should Know
Zacks via Yahoo Singapore Finance· 2 days agoThe most recent trading session ended with AbbVie (ABBV) standing at $169.91, reflecting a +1.05%...
Dividend Investors: Don't Be Too Quick To Buy AbbVie Inc. (NYSE:ABBV) For Its Upcoming Dividend
Simply Wall St. via Yahoo Singapore Finance· 2 days agoRegular readers will know that we love our dividends at Simply Wall St, which is why it's exciting...
Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value
GuruFocus.com via Yahoo Singapore Finance· 4 days agoIn this article, we will take a look into AbbVie Inc's (NYSE:ABBV) DCF analysis, a reliable and...
The Zacks Analyst Blog Highlights Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian
Zacks via Yahoo Singapore Finance· 2 days agoStocks recently featured in the blog include: Novo Nordisk A/S NVO, AbbVie Inc. ABBV, AstraZeneca...
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo Singapore Finance· 5 days agoThe NYSE ARCA Pharmaceutical Index declined 1.67% in the last five trading sessions. In the last...
Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal
Reuters via Yahoo Singapore Finance· 5 days ago(Reuters) -Eli Lilly agreed to buy Morphic Holding for $3.2 billion in cash, the companies said on...
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
Zacks via Yahoo Singapore Finance· 5 days agoThe traditional ways to plan for your retirement may mean income can no longer cover expenses...
If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Singapore Finance· 3 days agoThe company’s ENHANZE drug delivery technology helps in developing SC formulation of drugs. Several...